Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Article CAS PubMed Google Scholar
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49. https://doi.org/10.1111/apm.1965.64.1.31.
Article CAS PubMed Google Scholar
Chen YC, Fang WL, Wang RF, Liu CA, Yang MH, Lo SS, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016;22(1):197–202. https://doi.org/10.1007/s12253-015-9996-6.
Article CAS PubMed Google Scholar
Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: emerging mechanisms of tumor initiation and progression. Biochim Biophys Acta Rev Cancer. 2022;1877(3): 188719. https://doi.org/10.1016/j.bbcan.2022.188719.
Article CAS PubMed Google Scholar
WHO Classification of Tumours. Digestive system tumours: WHO classification of tumours, vol. 1. Geneva: World Health Organization; 2019.
Petrelli F, Berenato R, Turati L, Mennitto A, Steccanella F, Caporale M, et al. Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis. J Gastrointest Oncol. 2017;8(1):148–63. https://doi.org/10.21037/jgo.2017.01.10.
Article PubMed PubMed Central Google Scholar
Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study. World J Surg. 2002;26(9):1160–5. https://doi.org/10.1007/s00268-002-6344-2.
Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105–13. https://doi.org/10.1097/SLA.0000000000002040.
Koemans WJ, Luijten J, van der Kaaij RT, Grootscholten C, Snaebjornsson P, Verhoeven RHA, et al. The metastatic pattern of intestinal and diffuse type gastric carcinoma—a Dutch national cohort study. Cancer Epidemiol. 2020;69: 101846. https://doi.org/10.1016/j.canep.2020.101846.
Article CAS PubMed Google Scholar
Setia N, Wang CX, Lager A, Maron S, Shroff S, Arndt N, et al. Morphologic and molecular analysis of early-onset gastric cancer. Cancer. 2021;127(1):103–14. https://doi.org/10.1002/cncr.33213.
Article CAS PubMed Google Scholar
Lee JY, Gong EJ, Chung EJ, Park HW, Bae SE, Kim EH, et al. The characteristics and prognosis of diffuse-type early gastric cancer diagnosed during health check-ups. Gut Liver. 2017;11(6):807–12. https://doi.org/10.5009/gnl17033.
Article PubMed PubMed Central Google Scholar
Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomark Prev. 2009;18(7):1945–52. https://doi.org/10.1158/1055-9965.EPI-09-0250.
Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128(7):765–70. https://doi.org/10.5858/2004-128-765-DTITIA.
Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338–49. https://doi.org/10.1038/s41571-023-00747-0.
Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991;83(9):640–3. https://doi.org/10.1093/jnci/83.9.640.
Article CAS PubMed Google Scholar
Sasazuki S, Sasaki S, Tsugane S, Japan Public Health Center Study G. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer. 2002;101(6):560–6. https://doi.org/10.1002/ijc.10649.
Article CAS PubMed Google Scholar
Jang J, Lee S, Ko KP, Abe SK, Rahman MS, Saito E, et al. Association between body mass index and risk of gastric cancer by anatomic and histologic subtypes in over 500,000 East and Southeast Asian Cohort Participants. Cancer Epidemiol Biomark Prev. 2022;31(9):1727–34. https://doi.org/10.1158/1055-9965.EPI-22-0051.
Rota M, Pelucchi C, Bertuccio P, Matsuo K, Zhang ZF, Ito H, et al. Alcohol consumption and gastric cancer risk—a pooled analysis within the StoP project consortium. Int J Cancer. 2017;141(10):1950–62. https://doi.org/10.1002/ijc.30891.
Article CAS PubMed Google Scholar
Omofuma OO, Cook MB, Abnet CC, Camargo MC. Race and ethnicity, stage-specific mortality, and cancer treatment in esophageal and gastric cancers: surveillance, epidemiology, and end results (2000–2018). Gastroenterology. 2023;164(3):473–5. https://doi.org/10.1053/j.gastro.2022.11.032. (e4).
Tavakkoli A, Pruitt SL, Hoang AQ, Zhu H, Hughes AE, McKey TA, et al. Ethnic disparities in early-onset gastric cancer: a population-based study in Texas and California. Cancer Epidemiol Biomark Prev. 2022;31(9):1710–9. https://doi.org/10.1158/1055-9965.EPI-22-0210.
Jin H, Pinheiro PS, Callahan KE, Altekruse SF. Examining the gastric cancer survival gap between Asians and whites in the United States. Gastric Cancer. 2017;20(4):573–82. https://doi.org/10.1007/s10120-016-0667-4.
Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–9. https://doi.org/10.1038/nature13480.
Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by The Cancer Genome Atlas Project. Clin Cancer Res. 2017;23(15):4441–9. https://doi.org/10.1158/1078-0432.CCR-16-2211.
Article CAS PubMed PubMed Central Google Scholar
Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449–56. https://doi.org/10.1038/nm.3850.
Article CAS PubMed Google Scholar
Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9(1):1777. https://doi.org/10.1038/s41467-018-04179-8.
Article CAS PubMed PubMed Central Google Scholar
Lei Z, Tan IB, Das K, Deng N, Zouridis H, Pattison S, et al. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology. 2013;145(3):554–65. https://doi.org/10.1053/j.gastro.2013.05.010.
Article CAS PubMed Google Scholar
Ho SWT, Sheng T, Xing M, Ooi WF, Xu C, Sundar R, et al. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut. 2023;72(2):226–41. https://doi.org/10.1136/gutjnl-2021-326483.
Article CAS PubMed Google Scholar
Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012. https://doi.org/10.1038/s41467-018-03121-2.
Article CAS PubMed PubMed Central Google Scholar
Kim SK, Kim HJ, Park JL, Heo H, Kim SY, Lee SI, et al. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer. Gastric Cancer. 2020;23(3):473–82. https://doi.org/10.1007/s10120-019-01029-4.
Comments (0)